SPI Spire Healthcare Group plc
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, digestive and bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, the company provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee replacement treatment, and heart and kidney treatments. Further, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal neurosurgery, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, the company provides treatments in the areas of breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.…
Industry Peers
Medical Care FacilitiesKey Statistics
About Spire Healthcare Group (LON: SPI)
›
Spire Healthcare Group (LON: SPI) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 17,800 employees.
The shares were at 248.00 GBp on 20 November 2026, up 10.0% over 52 weeks. Its 52-week range is 140.80 GBp to 249.50 GBp, and it trades at the top of that range.
Its market capitalisation is 991.48M GBP. It pays a dividend yielding 0.61% (it pays out 57% of its earnings), against a median of 0.75% among the dividend payers in that peer group.
Spire Healthcare Group reports return on equity of 2.2%, an operating margin of 7.6% and revenue down 0.5% year over year.
Its debt exceeds its cash by 1.28B GBP, a debt-to-equity ratio of 1.77. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 4 analysts cover the stock, with an average rating of Hold; their mean price target of 258.00 GBp is 4.0% above the current price. The next earnings report is expected on 4 March 2027.